1-10 of 10
Mark B Juckett
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Impact of Stem Cell Mobilization Regimen on Outcomes after Autologous Transplant for Multiple Myeloma

Aimee Marie Merino, Ryan Shanley, Jenna Langer, Faridullah Rashid, Emily John, Mark B Juckett, Jeffrey S Miller, Daniel Weisdorf
Journal: Blood
Blood (2024) 144 (Supplement 1): 2098.
https://doi.org/10.1182/blood-2024-209402
Published: 2024
Journal Articles

Prognostic Understanding for Older, Medically Infirm, and/or Frail Recipients of Allogeneic Hematopoietic Cell Transplantation in an Ongoing Seamless Phase 2/3 Randomized Interventional Trial (ACE-BMT)

Elizabeth T. Loggers, James Fausto, Matthew Givens, Mei-Ean Yeow, Reena V. Jayani, Hassan B Alkhateeb, Laura A Schoenherr, Michael W. Rabow, Mark B Juckett, George Carrum, Joseph Uberti, Kyle Neale, Santiago Lopez, Diana Martins-Welch, Jeanette G Ferrer, Laura S Rhee, Drew A Rosielle, Susan McInnes, Jason A Webb, Rachel J. Cook, Elisheva Newman, Ronald Sobecks, Laura Johnston, Mohamed Sorror
Journal: Blood
Blood (2024) 144 (Supplement 1): 2297.
https://doi.org/10.1182/blood-2024-212281
Published: 2024
Journal Articles

Predictive Modeling of Hematopoietic Stem Cell Transplant Outcomes: Discovering the Role of Immunogenetic Features through Machine Learning Models

Simona Pagliuca, Carmelo Gurnari, Arda Durmaz, Ashwin Kishtagari, Zain Virk, Lukasz P. Gondek, Matthew Guo, Maria Bettinotti, Mark B Juckett, Qing Cao, Suresh Kumar Balasubramanian, Vikram Dhillon, Ben K. Tomlinson, Koen van Besien, Alice Aarnink, Marie Thérèse Rubio, Valeria Visconte, Jaroslaw Maciejewski
Journal: Blood
Blood (2024) 144 (Supplement 1): 927.
https://doi.org/10.1182/blood-2024-210565
Published: 2024
Journal Articles

Ziftomenib Combined with Venetoclax/Azacitidine in Relapsed/Refractory NPM1 -m or KMT2A -r Acute Myeloid Leukemia: Interim Phase 1a Results from KOMET-007

Amir T. Fathi, Ghayas C. Issa, Eunice S. Wang, Harry Erba, Jessica Kaplan Altman, Suresh Kumar Balasubramanian, Gail J. Roboz, Gary J. Schiller, Christine M. McMahon, Neil D. Palmisiano, Mark B Juckett, Yazan F. Madanat, Marcello Rotta, Keith W. Pratz, George Yaghmour, Kalyan Nadiminti, Helen Wei, Marcie Riches, Daniel Corum, Mollie Leoni, Stephen Dale, Amer M. Zeidan
Journal: Blood
Blood (2024) 144 (Supplement 1): 2880.
https://doi.org/10.1182/blood-2024-199170
Published: 2024
Journal Articles

Utilization of Leftover Autologous Peripheral Blood Stem Cells (PBSCs) in Patients with Multiple Myeloma (MM)

Natalie S Callander, MD, Walter L. Longo, MD, Mark B. Juckett, MD, Vaishalee P. Kenkre, MD, Peiman Hematti, MD, Janelle McMannes, Rebecca K Evans, Linda A Eckstein, MSN,NP, Blythe Gage, NP
Journal: Blood
Blood (2014) 124 (21): 2654.
https://doi.org/10.1182/blood.V124.21.2654.2654
Published: 2014
Journal Articles

Recovery Of Natural Killer Cells and Monocyte Subsets Following Autologous Peripheral Blood Stem Cell Transplantation Predicts Longer Progression Free Survival Among Multiple Myeloma Patients

Natalie S Callander, MD, Paul J Rathouz, PhD, Fotis Asimakopoulos, MBBChir, PhD, Mark B Juckett, MD, Christopher L Coe, PhD, Dagna Sheerar, BS, Karen Ersland, PhD, Peiman Hematti, MD, Erin S Costanzo, PhD
Journal: Blood
Blood (2013) 122 (21): 2126.
https://doi.org/10.1182/blood.V122.21.2126.2126
Published: 2013
Journal Articles

Reducing the Risk for Transplant Related Mortality After Allogeneic Hematopoietic Cell Transplantation: How Much Progress Has Been Made?.

John Horan, MD, MPH, Brent R. Logan, PhD, Manza-A. Agovi, MPH, Hillard M Lazarus, MD, Andrea Bacigalupo, MD, Karen Ballen, Rodrigo Martino, Mark B. Juckett, MD, Hanna J. Khoury, MD, Christopher Bredeson, MD, Vikas Gupta, Franklin O. Smith, MD, Gregory Hale, Matthew Carabasi, MD, Philip L. McCarthy, MD, J. Douglas Rizzo, MD, MS, Marcelo C. Pasquini, MD
Journal: Blood
Blood (2009) 114 (22): 649.
https://doi.org/10.1182/blood.V114.22.649.649
Published: 2009
Journal Articles

The Addition of Bevacizumab (B) to Lenalidomide and Low Dose Dexamethasone Does Not Significantly Increase Response in Relapsed or Refractory Multiple Myeloma (NCI#7317).

Natalie Scott Callander, MD, Stephanie Markovina, BA, Mark B. Juckett, MD, Elizabeth Wagner, MA, Jill Kolesar, Walter Longo, Eliot C. Williams, MD, PhD, Kyungmann Kim, Jae Werndli, BSc, MSc, Shigeki Miyamoto, PhD
Journal: Blood
Blood (2009) 114 (22): 3885.
https://doi.org/10.1182/blood.V114.22.3885.3885
Published: 2009
Journal Articles

A Pilot Study for Using 3′-Deoxy-3′-[ 18 f]Fluorothymidine Positron Emission Tomography ([18F]FLT PET/CT) Imaging for Early Assessment of Response to Induction Chemotherapy in Acute Myeloid Leukemia (AML)

Mark B. Juckett, MD, Matt Vanderhoek, Scott Perlman, Robert Nickles, Robert Jeraj
Journal: Blood
Blood (2008) 112 (11): 2550.
https://doi.org/10.1182/blood.V112.11.2550.2550
Published: 2008
Journal Articles

Thalidomide (HAL) Maintenance Following High-Dose Melphalan with Autologous Stem Cell Transplant (ASCT) for Myeloma.

Julie E. Chang, MD, Mark B. Juckett, MD, Brad S. Kahl, MD, Teri L. Mitchell, Ronald E. Gangnon, PhD, Natalie S. Callander, MD, Walter L. Longo, MD
Journal: Blood
Blood (2006) 108 (11): 5455.
https://doi.org/10.1182/blood.V108.11.5455.5455
Published: 2006